Triferic AVNU is a Intravenous Solution in the Human Prescription Drug category. It is labeled and distributed by Rockwell Medical Inc.. The primary component is Ferric Pyrophosphate Citrate.
Product ID | 57278-318_a2a165ea-cb4f-d747-e053-2995a90a9f10 |
NDC | 57278-318 |
Product Type | Human Prescription Drug |
Proprietary Name | Triferic AVNU |
Generic Name | Ferric Pyrophosphate Citrate |
Dosage Form | Solution |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2020-03-30 |
Marketing Category | NDA / NDA |
Application Number | NDA212860 |
Labeler Name | Rockwell Medical Inc. |
Substance Name | FERRIC PYROPHOSPHATE CITRATE |
Active Ingredient Strength | 2 mg/mL |
Pharm Classes | Iron [CS],Parenteral Iron Replacement [EPC],Phosphate Binder [EPC],Phosphate Chelating Activity [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |
Marketing Start Date | 2020-03-30 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA212860 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2020-03-30 |
Marketing Category | NDA |
Application Number | NDA212860 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2020-03-30 |
Ingredient | Strength |
---|---|
FERRIC PYROPHOSPHATE CITRATE | 1.5 mg/mL |
SPL SET ID: | 51197a48-6078-42cd-b5ed-5ea22b6757b4 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
57278-318 | Triferic AVNU | ferric pyrophosphate citrate |
60940-029 | Triferic AVNU | ferric pyrophosphate citrate |
57278-315 | Triferic | FERRIC PYROPHOSPHATE CITRATE |
57278-316 | Triferic | Ferric Pyrophosphate Citrate |
64811-315 | Triferic | FERRIC PYROPHOSPHATE CITRATE |
60940-022 | Triferic Solution for Hemodialysis | ferric pyrophosphate citrate |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
TRIFERIC AVNU 88902817 not registered Live/Pending |
ROCKWELL MEDICAL, INC. 2020-05-06 |